Terms: = Germ cell tumor AND PAX3, MGC120382, 5077, ENSG00000135903, CDHS, MGC120383, HUP2, P23760, WS1, MGC120384, MGC134778, MGC120381 AND Treatment
23 results:
1. [Clinical analysis of 12 cases of laryngeal neuroendocrine carcinoma].
Xu NW; Ji YJ; Zhuo HD; Wang YJ; Qi XP; Xue JM; An YF; Suo LM; Zhao CQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Nov; 57(11):1334-1338. PubMed ID: 36404660
[No Abstract] [Full Text] [Related]
2. Restoration of functional pax3 transcriptional factor enhanced neuronal differentiation in pax3b isoform-depleted neuroblastoma cells.
Muralidharan N; Murugan A; Raj PA; Jothi M
Cell Tissue Res; 2023 Jan; 391(1):55-65. PubMed ID: 36378335
[TBL] [Abstract] [Full Text] [Related]
3. Melanocyte progenitor cells reside in human subcutaneous adipose tissue.
Ikeda Y; Wada A; Hasegawa T; Yokota M; Koike M; Ikeda S
PLoS One; 2021; 16(8):e0256622. PubMed ID: 34432824
[TBL] [Abstract] [Full Text] [Related]
4. A pax3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITF
Smith MP; Rana S; Ferguson J; Rowling EJ; Flaherty KT; Wargo JA; Marais R; Wellbrock C
Pigment Cell Melanoma Res; 2019 Mar; 32(2):280-291. PubMed ID: 30277012
[TBL] [Abstract] [Full Text] [Related]
5. Autophagy-dependent crosstalk between GILT and PAX-3 influences radiation sensitivity of human melanoma cells.
Hathaway-Schrader JD; Doonan BP; Hossain A; Radwan FFY; Zhang L; Haque A
J Cell Biochem; 2018 Feb; 119(2):2212-2221. PubMed ID: 28857256
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of Nucleotide Synthesis Targets Brain tumor Stem cells in a Subset of Glioblastoma.
Laks DR; Ta L; Crisman TJ; Gao F; Coppola G; Radu CG; Nathanson DA; Kornblum HI
Mol Cancer Ther; 2016 Jun; 15(6):1271-8. PubMed ID: 27196770
[TBL] [Abstract] [Full Text] [Related]
7. A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in pax3-Expressing cells.
Misuraca KL; Hu G; Barton KL; Chung A; Becher OJ
Neoplasia; 2016 Jan; 18(1):60-70. PubMed ID: 26806352
[TBL] [Abstract] [Full Text] [Related]
8. Transcriptional profiles of pilocytic astrocytoma are related to their three different locations, but not to radiological tumor features.
Zakrzewski K; Jarząb M; Pfeifer A; Oczko-Wojciechowska M; Jarząb B; Liberski PP; Zakrzewska M
BMC Cancer; 2015 Oct; 15():778. PubMed ID: 26497896
[TBL] [Abstract] [Full Text] [Related]
9. Targeting melanocyte and melanoma stem cells by 8-hydroxy-2-dipropylaminotetralin.
Bonchak JG; Eby JM; Willenborg KA; Chrobak D; Henning SW; Krzywiec A; Johnson SL; Le Poole IC
Arch Biochem Biophys; 2014 Dec; 563():71-8. PubMed ID: 25132642
[TBL] [Abstract] [Full Text] [Related]
10. Circulating tumor cells as prognostic biomarkers in cutaneous melanoma patients.
Kiyohara E; Hata K; Lam S; Hoon DS
Methods Mol Biol; 2014; 1102():513-22. PubMed ID: 24258996
[TBL] [Abstract] [Full Text] [Related]
11. A STATement on vemurafenib-resistant melanoma.
Hartsough EJ; Aplin AE
J Invest Dermatol; 2013 Aug; 133(8):1928-9. PubMed ID: 23856932
[TBL] [Abstract] [Full Text] [Related]
12. pax3 is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells.
Xia L; Huang Q; Nie D; Shi J; Gong M; Wu B; Gong P; Zhao L; Zuo H; Ju S; Chen J; Shi W
Brain Res; 2013 Jul; 1521():68-78. PubMed ID: 23701726
[TBL] [Abstract] [Full Text] [Related]
13. Stat3-targeted therapies overcome the acquired resistance to vemurafenib in melanomas.
Liu F; Cao J; Wu J; Sullivan K; Shen J; Ryu B; Xu Z; Wei W; Cui R
J Invest Dermatol; 2013 Aug; 133(8):2041-9. PubMed ID: 23344460
[TBL] [Abstract] [Full Text] [Related]
14. Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma.
Hoshimoto S; Faries MB; Morton DL; Shingai T; Kuo C; Wang HJ; Elashoff R; Mozzillo N; Kelley MC; Thompson JF; Lee JE; Hoon DS
Ann Surg; 2012 Feb; 255(2):357-62. PubMed ID: 22202581
[TBL] [Abstract] [Full Text] [Related]
15. Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma.
Koyanagi K; O'Day SJ; Boasberg P; Atkins MB; Wang HJ; Gonzalez R; Lewis K; Thompson JA; Anderson CM; Lutzky J; Amatruda TT; Hersh E; Richards J; Weber JS; Hoon DS
Clin Cancer Res; 2010 Apr; 16(8):2402-8. PubMed ID: 20371696
[TBL] [Abstract] [Full Text] [Related]
16. Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation.
Dissanayake SK; Olkhanud PB; O'Connell MP; Carter A; French AD; Camilli TC; Emeche CD; Hewitt KJ; Rosenthal DT; Leotlela PD; Wade MS; Yang SW; Brant L; Nickoloff BJ; Messina JL; Biragyn A; Hoek KS; Taub DD; Longo DL; Sondak VK; Hewitt SM; Weeraratna AT
Cancer Res; 2008 Dec; 68(24):10205-14. PubMed ID: 19074888
[TBL] [Abstract] [Full Text] [Related]
17. Pediatric genitourinary tumors.
McLean TW; Castellino SM
Curr Opin Oncol; 2008 May; 20(3):315-20. PubMed ID: 18391632
[TBL] [Abstract] [Full Text] [Related]
18. [Transcription factors in the development and progression of melanoma].
Lesiak K; Sztiller-Sikorska M; Czyz M
Postepy Hig Med Dosw (Online); 2007 Oct; 61():576-95. PubMed ID: 17971761
[TBL] [Abstract] [Full Text] [Related]
19. Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression.
Ryu B; Kim DS; Deluca AM; Alani RM
PLoS One; 2007 Jul; 2(7):e594. PubMed ID: 17611626
[TBL] [Abstract] [Full Text] [Related]
20. Transfection of melanoma cells with antisense pax3 oligonucleotides additively complements cisplatin-induced cytotoxicity.
He SJ; Stevens G; Braithwaite AW; Eccles MR
Mol Cancer Ther; 2005 Jun; 4(6):996-1003. PubMed ID: 15956257
[TBL] [Abstract] [Full Text] [Related]
[Next]
